Bildkälla: Stockfoto

Annexin Pharmaceuticals: Strategy Update - Redeye

Annexin Pharmaceuticals' CEO, Anders Haegerstrand, Chief Scientific and Medical Officer, Anna Frostegård, and Head of Therapeutic Area Oncology, Alain Thibault, present the company’s strategic priorities and its commercial roll-out. Watch the replay from March 7.

Annexin Pharmaceuticals' CEO, Anders Haegerstrand, Chief Scientific and Medical Officer, Anna Frostegård, and Head of Therapeutic Area Oncology, Alain Thibault, present the company’s strategic priorities and its commercial roll-out. Watch the replay from March 7.
Börsvärldens nyhetsbrev
ANNONSER